Chemours Files 8-K for Regulation FD Disclosure

Ticker: CC · Form: 8-K · Filed: 2024-03-07T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, regulation-fd

Related Tickers: CC

TL;DR

Chemours filed a standard 8-K, no major news.

AI Summary

On March 6, 2024, The Chemours Company filed an 8-K to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form.

Why It Matters

This filing indicates Chemours is adhering to its disclosure obligations with the SEC, providing transparency to investors.

Risk Assessment

Risk Level: low — This is a routine filing that does not disclose new material information or significant risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to include Financial Statements and Exhibits.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported is March 6, 2024.

What is the principal executive office address of The Chemours Company?

The address of the principal executive offices is 1007 Market Street, Wilmington, Delaware 19801.

What is the IRS Employer Identification Number for The Chemours Company?

The IRS Employer Identification Number for The Chemours Company is 46-4845564.

Under which section of the Securities Exchange Act of 1934 is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0001193125-24-061056.txt : 20240307 0001193125-24-061056.hdr.sgml : 20240307 20240306212801 ACCESSION NUMBER: 0001193125-24-061056 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20240306 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240307 DATE AS OF CHANGE: 20240306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24727942 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 d806416d8k.htm 8-K 8-K Chemours Co false 0001627223 0001627223 2024-03-06 2024-03-06     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 6, 2024 Date of Report (Date of Earliest Event Reported)       The Chemours Company (Exact Name of Registrant as Specified in Its Charter)       Delaware   001-36794   46-4845564 (State or Other Jurisdiction Of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices) Registrant’s telephone number, including area code: (302) 773-1000     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 7.01 Regulation FD Disclosure. On March 6, 2024, The Chemours Company issued a press release announcing additional information regarding the previously disclosed Audit Committee review. A copy of the news release is furnished as Exhibit 99.1 and is incorporated herein by reference. The information furnished with this report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it will not be deemed incorporated by reference into any registration s

View on Read The Filing